BRIM Biotechnology Reports May 2026 Revenue of NT$0.82 Million, Down 27.9% YoY
NQ Score
26/100
N1 Content Completeness
3
AI Summary (NQ-processed)
BRIM Biotechnology (6885) announced its consolidated revenue for May 2026 at NT$822,000 (approx. NT$0.01 billion), representing a year-on-year decrease of 27.9%.
AI Analysis
Frequently Asked Questions
- Q: What is BRIM Biotechnology's revenue for May 2026?
- A: BRIM Biotechnology reported a revenue of NT$822,000 for May 2026, which is a decrease of 27.9% compared to the same month last year.
- Q: What is the stock code of BRIM Biotechnology?
- A: The stock code is 6885 on the Taiwan stock market, classified under the Biotechnology and Medical industry.
- Q: Why is BRIM Biotechnology's monthly revenue so low?
- A: As an early-stage drug development company, it has no commercialized products yet, leading to minimal and volatile monthly revenues.